tilUXZ45 201701012019121320191231med 3D rekonstruktion SKS 3 tilUXZ45 202001012019121325000101med 3D rekonstruktion (CT) SKS 1 tilUXZ79 202001012019121325000101anden specifikation til ultralydsprocedurer SKS 1 tilUXZ79A 202001012019121325000101med 3D ultralyd SKS 1 tilZDW13 202001012019121325000101behandles i samarbejde med European Reference Network (ERN) SKS 1 tilZM81603 200310012019121325000101cholangiokarcinom SKS 3 tilZM81604 200310012019121325000101cholangiokarcinom, direkte spredning SKS 3 tilZM81606 200310012019121325000101metastase, cholangiokarcinom SKS 3 tilZM81607 200310012019121325000101cholangiokarcinom, recidiv SKS 3 tilZM81609 200310012019121325000101cholangiokarcinom, usikkert om primært eller metastase SKS 3 tilZM816A3 202001012019121325000101large duct intrahepatisk cholangiokarcinom SKS 1 tilZM816B3 202001012019121325000101small duct intrahepatisk cholangiokarcinom SKS 1 tilZM81713 200310012019121325000101hepatocellulært karcinom, fibrolamellært SKS 3 tilZM81714 200310012019121325000101hepatocellulært karcinom, fibrolamellært, direkte spredning SKS 3 tilZM81716 200310012019121325000101metastase, hepatocellulært karcinom, fibrolamellært SKS 3 tilZM81717 200310012019121325000101hepatocellulært karcinom, fibrolamellært, recidiv SKS 3 tilZM81719 200310012019121325000101hepatocellulært karcinom, fibrolamellært, usik. prim.el.mts SKS 3 tilZM81743 202001012019121325000101hepatocellulært karcinom, clear celle type SKS 1 tilZM81744 202001012019121325000101hepatocellulært karcinom, clear celle type, dir. spredning SKS 1 tilZM81746 202001012019121325000101metastase, hepatocellulært karcinom, clear celle type SKS 1 tilZM81747 202001012019121325000101hepatocellulært karcinom, clear celle type, recidiv SKS 1 tilZM81749 202001012019121325000101hepatocell. karc., clear celle t., usikkert om prim.el.mts. SKS 1 tilZM817A0 202001012019121325000101hepatocellulært adenom, HNF1A-inaktiveret SKS 1 tilZM817A3 202001012019121325000101hepatocellulært karcinom, scirrøst SKS 1 tilZM817A4 202001012019121325000101hepatocellulært karcinom, scirrøst, direkte spredning SKS 1 tilZM817A6 202001012019121325000101metastase, hepatocellulært karcinom, scirrøst SKS 1 tilZM817A7 202001012019121325000101hepatocellulært karcinom, scirrøst, recidiv SKS 1 tilZM817A9 202001012019121325000101hepatocellulært karcinom, scirrøst, usikkert om prim.el.mts SKS 1 tilZM817B0 202001012019121325000101hepatocellulært adenom, inflammatorisk SKS 1 tilZM817B3 202001012019121325000101hepatocellulært karcinom, steatohepatitisk SKS 1 tilZM817B4 202001012019121325000101hepatocellulært karcinom, steatohepatitisk, dir. spredning SKS 1 tilZM817B6 202001012019121325000101metastase, hepatocellulært karcinom, steatohepatitisk SKS 1 tilZM817B7 202001012019121325000101hepatocellulært karcinom, steatohepatitisk, recidiv SKS 1 tilZM817B9 202001012019121325000101hepatocellulært karcinom, steatohepat., us om prim.el.mts SKS 1 tilZM817C0 202001012019121325000101hepatocellulært adenom, beta-catenin aktiveret SKS 1 tilZM817C3 202001012019121325000101hepatocellulært karcinom, makrotrabekulært massivt SKS 1 tilZM817C4 202001012019121325000101hepatocellulært karcinom, makrotrabekulært massivt, dir.spr. SKS 1 tilZM817C6 202001012019121325000101metastase, hepatocellulært karc., makrotrabekulært massivt SKS 1 tilZM817C7 202001012019121325000101hepatocellulært karcinom, makrotrabekulært massivt, recidiv SKS 1 tilZM817C9 202001012019121325000101hepatocellulært karc., makrotrab. massivt, us.om prim.el.mts SKS 1 tilZM817D0 202001012019121325000101hepatocellulært adenom, beta-cat. aktiveret inflammatorisk SKS 1 tilZM817D3 202001012019121325000101hepatocellulært karcinom, chromofobt SKS 1 tilZM817D4 202001012019121325000101hepatocellulært karcinom, chromofobt, direkte spredning SKS 1 tilZM817D6 202001012019121325000101metastase, hepatocellulært karcinom, chromofobt SKS 1 tilZM817D7 202001012019121325000101hepatocellulært karcinom, chromofobt, recidiv SKS 1 tilZM817D9 202001012019121325000101hepatocellulært karcinom, chromofobt, usik. om prim.el.mts SKS 1 tilZM817E3 202001012019121325000101hepatocellulært karcinom, neutrofilrigt SKS 1 tilZM817E4 202001012019121325000101hepatocellulært karcinom, neutrofilrigt, direkte spredning SKS 1 tilZM817E6 202001012019121325000101metastase, hepatocellulært karcinom, neutrofilrigt SKS 1 tilZM817E7 202001012019121325000101hepatocellulært karcinom, neutrofilrigt, recidiv SKS 1 tilZM817E9 202001012019121325000101hepatocellulært karcinom, neutrofilrigt, us. om prim.el.mts SKS 1 tilZM817F3 202001012019121325000101hepatocellulært karcinom, lymfocytrigt SKS 1 tilZM817F4 202001012019121325000101hepatocellulært karcinom, lymfocytrigt, direkte spredning SKS 1 tilZM817F6 202001012019121325000101metastase, hepatocellulært karcinom, lymfocytrigt SKS 1 tilZM817F7 202001012019121325000101hepatocellulært karcinom, lymfocytrigt, recidiv SKS 1 tilZM817F9 202001012019121325000101hepatocellulært karcinom, lymfocytrigt, us. om prim.el.mts SKS 1 tilZM81803 200310012019121325000101kombineret hepatocellulært karcinom og cholangiokarcinom SKS 3 tilZM81804 200310012019121325000101komb. hepatocellulært karc. og cholangiokarc., dir.spredning SKS 3 tilZM81806 200310012019121325000101metastase, kombineret hepatocell. karc. og cholangiokarc. SKS 3 tilZM81807 200310012019121325000101kombineret hepatocellulært karc. og cholangiokarc., recidiv SKS 3 tilZM81809 200310012019121325000101komb. hepatoc. karc. og cholangiokarc., usik om prim el mts SKS 3 tilZM83901 202001012019121325000101adnekstumor SKS 1 tilZM849A3 202001012019121325000101poorly cohesive karcinom SKS 1 tilZM849A4 202001012019121325000101poorly cohesive karcinom, direkte spredning SKS 1 tilZM849A6 202001012019121325000101metastase, poorly cohesive karcinom SKS 1 tilZM849A7 202001012019121325000101poorly cohesive karcinom, recidiv SKS 1 tilZM849A9 202001012019121325000101poorly cohesive karcinom, usikkert om primært eller mts. SKS 1 tilZM850B0 202001012019121325000101intraduktal papillær neopl. m. low grade intraepit. neopl. SKS 1 tilZM850B2 202001012019121325000101intraduktal papillær neopl. m. high grade intraepit. neopl. SKS 1 tilZM850B3 202001012019121325000101intraduktal papillær neopl. m. assoc. invasivt karcinom SKS 1 tilZM85800 200310012019121320191231benignt tymom SKS 3 tilZM85801 200310012019121320191231tymom SKS 3 tilZM85801 202001012019121325000101mikronodulært thymom med lymfoidt stroma SKS 1 tilZM85803 202001012019121325000101thymom SKS 1 tilZM85804 202001012019121325000101thymom, direkte spredning SKS 1 tilZM85806 202001012019121325000101metastase, thymom SKS 1 tilZM85807 202001012019121325000101thymom, recidiv SKS 1 tilZM85809 202001012019121325000101thymom, usikkert om primært eller metastase SKS 1 tilZM85811 200901012019121320191231tymom, type A SKS 3 tilZM85813 202001012019121325000101thymom, type A SKS 1 tilZM85821 200901012019121320191231tymom, type AB SKS 3 tilZM85823 202001012019121325000101thymom, type AB SKS 1 tilZM85831 200901012019121320191231tymom, type B1 SKS 3 tilZM85833 202001012019121325000101thymom, type B1 SKS 1 tilZM85841 200901012019121320191231tymom, type B2 SKS 3 tilZM85843 202001012019121325000101thymom, type B2 SKS 1 tilZM85851 200901012019121320191231tymom, type B3 SKS 3 tilZM85853 202001012019121325000101thymom, type B3 SKS 1 tilZM85863 200901012019121325000101thymuskarcinom SKS 3 tilZM85864 200901012019121325000101thymuskarcinom, direkte spredning SKS 3 tilZM85866 200901012019121325000101metastase, thymuskarcinom SKS 3 tilZM85867 200901012019121325000101thymuskarcinom, recidiv SKS 3 tilZM85869 200901012019121325000101thymuskarcinom, usikkert om primært eller metastase SKS 3 tilZM85870 201401012019121325000101ektopisk hamartomatøst thymom SKS 3 tilZM858A3 201810012019121325000101ektopisk thymom SKS 3 tilZM858A4 201810012019121325000101ektopisk thymom, direkte spredning SKS 3 tilZM858A6 201810012019121325000101metastase, ektopisk thymom SKS 3 tilZM858A7 201810012019121325000101ektopisk thymom, recidiv SKS 3 tilZM858A9 201810012019121325000101ektopisk thymom, usikkert om primært eller metastase SKS 3 tilZM87701 202001012019121325000101atypisk Spitz tumor SKS 1 tilZM87801 202001012019121325000101pigmenteret epiteloidt melanocytom SKS 1 tilZM89660 202001012019121325000101renomedullær interstitielcelletumor SKS 1 tilZM959A2 202001012019121325000101B-lymfom, uklas., intermed.ml. DLBCL og CHL, inkomp. remis. SKS 1 tilZM959A3 202001012019121325000101B-lymfom, uklassificerbar, intermediært mellem DLBCL og CHL SKS 1 tilZM959A7 202001012019121325000101B-lymfom, uklas., intermediært mellem.DLBCL og CHL, recidiv SKS 1 tilZM959A8 202001012019121325000101B-lymfom, uklas., intermediært ml.DLBCL og CHL, i remission SKS 1 tilZM968G2 200901012019121320191231B-lymom, uklas., intermed.ml. DLBCL og CHL, inkomp. remis. SKS 3 tilZM968G3 200901012019121320191231B-lymfom, uklassificerbar, intermediært mellem DLBCLog CHL SKS 3 tilZM968G7 200901012019121320191231B-lymfom, uklass., intermediært mellem.DLBCL og CHL, recidiv SKS 3 tilZM968G8 200901012019121320191231B-lymfom, uklas., intermediært ml.DLBCL og CHL, i remission SKS 3 tilZRRF 202001012019121325000101PI-RADS (Prostate Imaging-Reporting and Data System) score SKS 1 tilZRRF01 202001012019121325000101PI-RADS 1 SKS 1 tilZRRF02 202001012019121325000101PI-RADS 2 SKS 1 tilZRRF03 202001012019121325000101PI-RADS 3 SKS 1 tilZRRF04 202001012019121325000101PI-RADS 4 SKS 1 tilZRRF05 202001012019121325000101PI-RADS 5 SKS 1 tilZRRFXX 202001012019121325000101PI-RADS ikke gennemført SKS 1